For those of you who work in the drug and alcohol field in NSW, this is a reminder that you can access and utilise the NSW Health Drug & Alcohol Health Services Library.
We are a state-wide service offering assistance with a range of drug and alcohol related information needs to NSW drug health professionals.
We can assist you with any work-related research you may require; access to a variety of drug and alcohol journals, books/reports and videos/DVDs.
We can remotely service clients anywhere in NSW – either via email delivery of documents, or posting those physical materials that cannot be delivered electronically.
If you would like further information please contact me directly, or go to our website www.dahsl.org.au for further details.
Category Archives: Professional News
The Inaugural Medicine in Addiction Conference
Great to see the College of GPs jumping boots and all into the area:
The Inaugural Medicine in Addiction Conference
March 18-20 2011
Citiclub Hotel
113 Queen St, MelbourneThe Royal Australian and New Zealand College of Psychiatrists (RANZCP) Section of Addiction Psychiatry and the Royal Australian College of General Practitioners (RACGP) are delighted to present this first time event taking place in the sophisticated urban setting of the city of Melbourne.
An exciting and diverse scientific program will offer those in attendance an insight into the problem of addiction and dependency in a range of clinical settings, and will include keynote presentations from Prof Paul Haber, Prof Dan Lubman, A/Prof Nick Lintzeris, Prof Andrew Lawrence, Prof Jason White and A/ Prof Kate Conigrave to name but a few. A thought provoking and lively debate will also feature.
The registration form can be downloaded here or visit the conference website for more details including program updates.
Injecting bath salts: fact, hysteria or both?
From the New York Times – my take is the reality is probably somewhere in the middle, as usual.
When Neil Brown got high on bath salts, he took his skinning knife and slit his face and stomach repeatedly. Brown survived, but authorities say others haven’t been so lucky after snorting, injecting or smoking powders with such innocuous-sounding names as Ivory Snow, Red Dove and Vanilla Sky.
Law enforcement agents and poison control centers say the bath salts, with their complex chemical names, are an emerging menace in several U.S. states where authorities talk of banning their sale. Some say their effects can be as powerful as those of methamphetamine.
Writeup of gambling seminar
From Dr Andrew Byrne:
Concord Seminar summary on gambling issues. Tuesday 3rd August 2010.
The 4th Concord Seminar of 2010, “Is pathological gambling an addiction? You bet it may or may not be!” was presented by Alex Blaszczynski, Professor of Clinical Psychology and Director of the Gambling Treatment Clinic at the School of Psychology, University of Sydney. He has written a self-help manual, “Overcoming Compulsive Gambling”. He is editor of International Gambling Studies and Assistant Regional Editor for the journal ‘Addiction’.
The presentation covered the definitions and epidemiology of problem and pathological gambling, their impacts on self and others; the multifactorial etiology of gambling problems; cognitive distortions and implications for treatment; and the “pathways” model for understanding etiology and matching treatment interventions.
While pathological gambling (PG) (recurrent gambling despite severe negative consequences and/or repeated unsuccessful attempts to cease) remains classified in DSM -IV-TR (A.P.A., 2000) among the impulse control disorders (along with kleptomania and pyromania), its diagnostic criteria since DSM III have come more closely to resemble those substance use disorders. In DS-V, it is proposed to reclassify the condition as a non-substance behavioural addiction. By contrast, ‘problem’ gambling is defined by harms to the individual player, their family and/or the wider community. This resembles the definition of harmful substance use in ICD-10.
There has been a worldwide increase of legalized forms of gambling, starting in the USA in 1968 with the New Hampshire lotteries; in Australia with the 1973 West Point Casino; in Britain with the1978 Royal Commission into Gambling and large increases in Europe in the 1990s and in Asia in 2000s. Electronic gaming machines have become increasingly common while the current spectacular growth area is in online gambling.
The prevalence of moderate to severe problem gambling is similar in Australia (2.7%) and in the USA (3.0%). Estimates vary widely for prevalence of pathological gambling (Australia 0.6-1.2%; USA 0.1-1.9%), reflecting the assessment tools used (e.g., South Oaks Gambling Screen versus DSM criteria).
The DSM diagnosis of pathological gambling (PG) requires five or more of the following:
1. Preoccupation (psychological dependence & salience)
2. Increased amount gambled (tolerance)
3. Irritability/restlessness on cessation (withdrawal)
4. Escape from stress (negative reinforcement & motivation)
5. Chasing losses (erroneous & distorted cognitions)
6. Lying
7. Repeated failure to cease (impaired control)
8. Illegal acts
9. Risked significant relationships
10. ‘Bailout’ (relatives or friends paying gambling debts)The criteria of salience, tolerance, withdrawal, impaired control and continuing despite knowledge of harm have obvious parallels with substance dependence, and suggest the likely involvement of meso-limbic/orbito-frontal reward systems in positive and negative reinforcement, underpinning classical and operant conditioning in the development of craving, and impulsive decision-making in pathological gambling.
However, certain other features of pathological gambling bear less close comparison with substance dependence. One example is the mediating function of erroneous and distorted cognitions such as the “gambler’s fallacy”, the mistaken belief that the chances of winning over time increase (in fact the chances of winning remain the same at each point in time, and losses are cumulative over time). A recent published paper (Slutske et al 2010), reported that recovery from PG is commonly achieved in the absence of abstinence, ie with a return to “controlled gambling”, a further difference from most instances of substance dependence, where a return to controlled use is exceptional (see Stanton Peele for the contrary view for alcohol and drug use).
Indeed the significance of tolerance or withdrawal, two defining elements of “gambling as an addiction”, remains unclear. A recent study (Blaszczynski et al 2008) found that increased bet size was not related to the need to maintain excitement or arousal levels, as in an addictive model, but rather were consistent with a cognitive model in which accumulating debts coupled with erroneous perceptions lead the gambler to increase bet size, with larger bets required to win enough to meet financial obligations. While withdrawal features in gambling are comparable in severity and character (depression, general discomfort, irritability/agitation, restlessness, anxiety and headache) to alcohol withdrawal, it remains unclear whether these symptoms “result from the inability to gamble or from the loss of an avoidant stress coping strategy”.
As for substance dependence, gambling has a multifactorial etiology. There is a strong association of PG with parental gambling and genetic transmission is estimated to account for 40-54% of variance of risk for developing PG (Shah et al., 2005). Other factors include environmental factors such as access to venues, ease of accessing money, advertising, community and cultural attitudes, ethnicity and lower socioeconomic status.
In terms of comorbidity, 40% of PG have current substance use disorders, 75% suffer major depression, 40% report serious suicidal ideation. It is estimated that approximately 1.7% of Australian suicides are gambling-related. PGs score high for impulsivity, risk-taking, substance use disorders, and borderline, anti-social, narcissistic personalities. Some 60% commit illegal acts to support their habit, usually non-violent property crimes.
There are gender differences, in that men are more likely to engage in wagering and online and sports gambling; women have a bimodal distribution of young and 45yo gambling. Early onset (before age 20) is almost universal in PG, fostered by family examples of gambling, and gifts such as scratch lotteries. The average age at treatment seeking is in the mid to late 30s.
The problems associated with problem and pathological gambling are wide ranging, as the person slips into borrowing and financial strife, sometimes into theft and lying, with impacts on work, legal problems, family problems including neglect, domestic violence and family breakdown, increasing stress, worry and depression, even personality change (irritability, becoming withdrawn).
The impacts on spouses can be enormous, including loss of trust and sense of security, loss of savings, superannuation, even the marital home, or the partner forced to resume or increase work hours. Domestic violence, emotional and physical and verbal abuses are common (often against the gambler). Children of gamblers may suffer confusion, insecurity and poor self esteem, emotional neglect, exposure to domestic arguments/violence, as well as adverse role modeling and vicarious learning.
By way of example, Professor Blaszczynski drew our attention to the structural characteristics of electronic gaming machines (EGMs). They operate within a social, alcohol-licensed environment and provide continuous, rapid cycle, multi-line multi-credits, many near wins, requiring minimal skill and fostering erroneous beliefs. The random ratio schedule of reinforcement (wins) is the most resistant to extinction of all reinforcement schedules, perhaps because of the intensity of the mounting excitement and arousal created by the unpredictability of a reward. This forms an interesting contrast to substance use disorders in that the effect of most psychoactive substances is, comparatively, predictable and constant (as long as the drug supply is secure).
Professor Blaszczynski pointed to the multiple factors interacting in an etiological model for PG: neurobiological/genetic factors as with substance dependence, interacting with personality and with environmental factors including family and peer group influences, and the wider socio-cultural setting of gambling.
This model resembles the bio-psycho-social framework generally used for conceptualising substance use disorders. One distinct difference however is the central role of belief schemas that have a mediating function in the development of problem and pathological gambling. These include the “gambler’s fallacy” mentioned above, but also superstitious beliefs (rituals, talismanic objects, cognitive ‘prayers’, promises, bargaining), biased evaluation, illusions of control and belief in the role of personal skill.
Erroneous cognitions are common in pathological gamblers (PG) and non-pathological gamblers alike, although superstitious beliefs are more common in PG, and PG are more likely to show make increasing estimates of the chances of winning during a session of play. Knowledge of the statistical reality of gambling itself does not prevent irrational beliefs during play.
The approaches to reducing harms from gambling, like those for substance use disorders, range of from public health measures to psychological and pharmacological therapies. As the risk of PG increases with consumption, measures to reduce overall consumption would be expected to have benefit: as with substance use disorders, consumption is skewed, with mean higher than median, and a small number of people accounting for a large amount of consumption. Taxation revenue incentives severely impede a regulatory public-health approach to gambling problems.
Self-help groups such as Gamblers Anonymous are effective for a significant minority of people. However, drop-out rates are very high.
Cognitive therapy is beneficial in 75-80% of cases resulting in the reduction of cognitive distortions and levels of gambling behaviour, motivation and urges to gamble. This form of therapy aims to inform gamblers that gaming machines are recreational devices on which you spend money: while it is possible to win in the short-term, in the long term, in all but the most unusual cases and extraordinary circumstances, this outcome is virtually impossible.
Behavioural interventions are designed to diminish the arousal associated with gambling, and include aversive therapy, imaginal desensitization, and stimulus control and cue exposure techniques. Positive outcomes are achieved in 20%-70% of PG with reduced arousal associated with gambling stimuli and consequently diminished urges to gamble.
The posited underlying neurobiological mechanisms of gambling suggest potential benefit of psychopharmacological interventions, however studies of lithium, SSRIs, naltrexone and olanzepine have given mixed and overall disappointing results. The studies to date have been limited by small size, high drop-out rates, short follow-up and varied outcome measures.
A further problem in evaluating treatments is that PGs do not form a homogeneous group. Accordingly, Blaszczynski and Nower (2002) have proposed a “pathways model” which distinguishes among three more or less distinct groups of PG, with implications for treatment matching.
A first pathway, encompassing mainly behaviourally conditioned gamblers, is characterized by a social context of gambling, with wins generating excitement, reinforcement and cognitive distortions leading to poor decisions. These people have less dissociation and more absorption in their gambling, briefer histories and either less severe gambling or rapid escalation in response to defined stress. They have a background of childhood and family stability, with less severe psychopathology. Substance abuse onset tends to follow rather than precede gambling problems. Cognitive-behavioural interventions are most likely to be effective with this group.
For the second and third pathways and for the second half of the seminar, and references, see the web site:
http://dependencyseminars.blogspot.com/2010/11/concord-seminar-summary-on-gambling.html
Fifth Annual Conference of the International Society for the Study of Drug Policy
This is the final call for papers for the Fifth Annual Conference of the International Society for the Study of Drug Policy which will be hosted by the Trimbos Institute on 23-24 May 2011 in Utrecht, Netherlands.
This conference should be of interest to policymakers, practitioners, and academics from a wide array of disciplines who are engaged in drug policy analyses pertaining to drug markets, the harms caused by both the supply of and demand for drugs, and the intended and unintended consequences of drug policy. The goal of this conference is to share information, findings and methods as well as to facilitate collaboration among a broad set of top international scholars and policy makers.
The deadline for submission of abstracts or panel proposals is January 15, 2011. Abstracts containing between 200 and 400 words and panel proposals should be submitted to issdp@trimbos.nl. Areas of particular interest include:· Supply reduction indicators: how to improve data and estimates of production, trafficking, wholesale or retail dealing, and money laundering
· Improving and utilizing cross-national comparisons of problems and policies
· Harm reduction principles and practices in the supply field
· Regulating regimes as alternative for prohibitionist regimes: example regulating cannabis production, wholesale distribution, and street sales
· What do drug policy evaluations produce: applicability and use of evaluations and other policy (relevant) studies
· Cost benefit analysis of policies and measures (e.g. alternatives to prison, targeting of substance abuse treatment and diversion programs for criminal offenders) paying specific attention on the issue how to measure lost welfare associated with drug prohibition
· Assessing the major influences on drug policy decision processes, including institutional, cultural and political factors, such as: political windows of opportunity (politics and political competition), institutional resources of policy-actors and advocacy groups.
Optional post-conference workshops will be held 25 May, 2011.Further information is available at http://www.trimbos.org/trimbos-international/agenda/issdp-conference-2011
URGENT REQUEST from the Global Burden of Disease – Illicit Drug Use Expert Group
From Prof Louisa Degenhardt – Chair, Illicit Drug Use Expert Group:
We are looking for data from around the world on hepatitis B and C (HBV and HCV) prevalence among injecting drug users (IDUs). Do you have data from your country?
As part of work we are conducting for the 2010 Global Burden of Disease Study, we are undertaking a systematic review of existing data on the prevalence of HBV and HCV among injecting drug users. This work is being overseen by the Illicit Drug Use Expert Group and a team of researchers with expertise in undertaking systematic reviews (see www.gbd.unsw.edu.au). This is one of the first attempts to quantify the extent to which viral hepatitis is an issue faced by people who inject drugs on a global scale. Such estimates are crucial building blocks to inform responses to viral hepatitis at country, regional and global levels.
We are in the process of making estimates for every country around the world on:
– the prevalence of HCV among IDUs
– the prevalence of HBV among IDUs, with separate estimates for
o hepatitis B surface antigen (HBsAg)
o antibody to hepatitis B core antigen (anti-HBc)Many of you may be familiar with the estimates that were released by the Reference Group to the UN on HIV and injecting drug use (see www.idurefgroup.com). We hope to produce a similar set of estimates for HBV and HCV. This is challenging because in many countries, data may not be widely available. We have conducted a large search of the peer-reviewed literature, and are gathering as much grey literature (such as NGO and government reports) as possible. However, there will be some material that our search would have missed.
Do you have any information that may be of use to us? Any assistance will be acknowledged in the reports we are writing on this subject. Due to the tight timelines of this project we can only consider material received by Monday 17 January 2011. Many thanks in anticipation of any information you can provide, and for circulating to other colleagues who may be able to assist.
Have a happy and safe holiday.
Paul Nelson,
on behalf of Prof Louisa Degenhardt
Chair, Illicit Drug Use Expert Group
2010 Global Burden of Disease Study
Please direct all correspondence to gbd@med.unsw.edu.au
Growing Up Solid: integrating emotional and mental health throughout infancy, childhood and adolescence
From the RANZCP:
Growing Up Solid
Joint RANZCP Faculty of Child and Adolescent Psychiatry and Australian Association for Infant Mental Health Conference
Growing Up Solid: integrating emotional and mental health throughout infancy, childhood and adolescence
12 – 14 May 2011
Perth, Western AustraliaThe AAIMHI and RANZCP Faculty of Child Psychiatry are delighted to host a joint conference, reflecting their commitment to the integration of understanding and treatment of mental illness from infancy to adulthood, encompassing different perspectives, organisations and cultures. Guests include international visitors from South Africa (Dr Astrid Berg), USA (Dr Karlen Lyons Ruth ) and UK (Ms Michelle Sleed and Prof Robin Murray), and West Australian / Victorian artist Mr Shaun Tan.
Abstracts are welcome from people working in the alcohol and other drug sector. The closing date for submissions has been extended until Saturday 15 January 2011.
For more information, please visit:
http://www.sapmea.asn.au/conventions/aaimhi&fcap2011/index.html
A Family Sensitive Policy and Practice Toolkit
An Invitation to a Launch:
A Family Sensitive Policy and Practice ToolkitYou and your colleagues are cordially invited to a launch of an important new NCETA resource entitled A Family Sensitive Policy and Practice Toolkit addressing child protection issues for workers in the alcohol and drug area.
The toolkit has been developed by the National Centre for Education and Training on Addiction (NCETA), Flinders University as part of it collaborative partnership with, and through funding from, the SA Department of Health. Development of the toolkit resulted from the collaboration between NCETA and Professor Dorothy Scott former Director, Australian Centre for Child Protection, University of South Australia. Members of the South Australian Family Drug and Alcohol Network (FADNET) also contributed to the development of parts of the toolkit.
The toolkit is the first resource of this type to be developed in Australia and it has both national and international application. It builds upon the growing need for a more comprehensive approach to understanding the causes, prevention and treatment of alcohol and other drug problems. The primary audience is the alcohol and other drugs sector including AOD practitioners, social workers, general practitioners, mental health professionals, psychologists, community health workers, health promotion staff and those working in the legal/justice system. It is also intended for professionals working in the Family and Child Welfare/Child Protection sector.
The kit is designed to enhance evidence-based practice and facilitate Family Sensitive Policy and Practice within alcohol and other drug treatment services. It takes a holistic, public health approach to addressing alcohol and other drug misuse and aims to mitigate the impact of that misuse upon children and other family members. The Family Sensitive Policy and Practice toolkit comprises:
· For Kids’ Sake: A workforce development resource for Family Sensitive Policy and Practice in the Alcohol and Other Drugs Sector
· Taking First Steps: What Family Sensitive Practice Means for Alcohol and Other Drug Worker – A Survey Report
· A Checklist for Family Sensitive Practice for the Alcohol and other Drug Field
· Family Sensitive Practice in the Alcohol and Other Drug Field (6 page summary flyer)
· A CD-Rom containing all of the above plus additional resources in electronic format.The toolkit will be launched by the Hon. John Hill, MP, Minister for Health and Minister for Mental Health and Substance Abuse at:
2.15pm Thursday 16 December, 2010
Flinders University City Campus
Room 1, Level 1
182 Victoria Square
Adelaide SAAfternoon tea and copies of the toolkit will be available at the launch.
RSVP: Tuesday 14 December 2010
nceta@flinders.edu.au
or Phone: (08) 8201 7535Please contact NCETA for a map for the venue location and parking details.
Registrations closing soon: Research into Practice Conference
Outside In: Research into Practice Conference
Date: Monday 6 and Tuesday 7 December 2010
Venue: Novotel Manly Pacific, 55 North Steyne , Manly, NSWThe Network of Alcohol and other Drugs Agencies (NADA) and the Mental Health Coordinating Council (MHCC) invite you to the Research into Practice Conference at the Novotel Manly Pacific in Sydney.
The conference will showcase NGO driven research in the area of working with clients with co-existing mental health and drug and alcohol problems, with a focus on the implications for practice. A highlight of the conference will be the diverse range of services, population groups and research partners that have been involved in the research.
The conference will be opened by the Hon Carmel Tebbutt MP, Deputy Premier and Minister for Health.
Keynote presenters include:
– Julian Morrow, Executive Producer and co-founder of The Chaser
– A/Prof Michael Baigent, Department of Psychiatry Flinders University, Clinical Advisor, beyondblue, the National Depression Initiative, Clinical Director, Centre for Anxiety and Related Disorders
– Dr Katherine Mills, Senior Lecturer and NHMRC Research Fellow, National Drug and Alcohol Research Centre
– Readings and performance by young artists from the “Speak Out Speak Easy” program at South Sydney Youth Services.Click here to download the conference flyer.
Click here to download the draft program.
Draft of the National Drug Strategy 2010-2015 – call for submissions
The Intergovernmental Committee on Drugs (IGCD) is developing the next stage of the National Drug Strategy on behalf of the Ministerial Council on Drug Strategy. A draft of the National Drug Strategy 2010-2015 has been developed based on an evaluation of the previous strategy and a round of consultations earlier this year.
Development of the Strategy represents a partnership between the Commonwealth Government, State and Territory governments, the non-government sector and the broader community. Public comment is now invited on the draft Strategy. These comments will be used to finalise a document that will steer Australia’s drug policy over the next five years.
You are encouraged to review the consultation draft and provide feedback to assist in the finalisation of the Strategy. The draft, as well as further information on how to be part of this consultation, is available at the National Drug Strategy website (www.nationaldrugstrategy.gov.au).Submissions close at 8pm (AEDT), 10 December 2010.
